View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäf...

EQS-News: SHS VIVEON AG / Schlagwort(e): Jahresbericht SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäftsjahr 2023 25.04.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäftsjahr 2023 München, 25. April 2024 – Die SHS Viveon AG („SHS Viveon“); (DE000A0XFWK2) hat am 25. April 2024 die Ergebnisse für das Geschäftsjahr 2023 veröffentlicht. Demnach erzielte das Unternehmen 2023 einen Konzernumsatz in Höhe von EUR 8,85 Mio. nach EUR 9,12 Mio. im Vorjahr. Im ...

 PRESS RELEASE

Standard BioTools Announces Operational Restructuring Plan to Drive Lo...

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while sup...

 PRESS RELEASE

Lakeland Financial Reports First Quarter Net Income of $23.4 Million a...

Lakeland Financial Reports First Quarter Net Income of $23.4 Million and 5% Annualized Average Loan Growth WARSAW, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $23.4 million for the three months ended March 31, 2024, which represents a decrease of $877,000, or 4%, compared with net income of $24.3 million for the three months ended March 31, 2023. Diluted earnings per share were $0.91 for the first quarter of 2024 and decreased 3% compared to $0.94 for the first quarter o...

 PRESS RELEASE

First Merchants Corporation Announces First Quarter 2024 Earnings Per ...

First Merchants Corporation Announces First Quarter 2024 Earnings Per Share MUNCIE, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation (NASDAQ - FRME) First Quarter 2024 Highlights: Net income available to common stockholders was $47.5 million and diluted earnings per common share totaled $0.80 compared to $63.6 million and $1.07 in the first quarter of 2023, and $42.0 million and $0.71 in the fourth quarter of 2023.   Net income and diluted earnings per common share, excluding non-core charges of $3.5 million incurred during the quarter, totaled $50.1 million and $0.8...

Topicus.com Inc: 1 director

A director at Topicus.com Inc bought 59,779,702 shares at 124.041CAD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

Sterling & Wilson Renewable Energy Ltd: 1 director

A director at Sterling & Wilson Renewable Energy Ltd sold 14,500 shares at 638.131INR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

Lifco AB: 2 directors

A director at Lifco AB bought 2,000 shares at 262.640SEK and the significance rating of the trade was 37/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024 LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release first quarter 2024 financial results on Monday, May 6, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern T...

 PRESS RELEASE

KKR to Acquire $1.64 Billion Student Housing Portfolio from BREIT

NEW YORK--(BUSINESS WIRE)-- KKR and Blackstone Real Estate Income Trust, Inc. (“BREIT”) today announced a definitive agreement for funds managed by KKR to acquire a portfolio of 19 purpose-built student housing properties from BREIT for approximately $1.64 billion. The over 10,000-bed portfolio is comprised of 19 purpose-built, premium student housing assets anchored to 14 leading four-year public universities across 10 states. The communities feature a wide range of best-in-class amenities and the majority are located with easy pedestrian access to campus. BREIT acquired this portfolio in 2...

 PRESS RELEASE

TÄYDENNYS – Sisäpiiritieto: Meriaura Groupin hallitus ehdolliseen päät...

TÄYDENNYS – Sisäpiiritieto: Meriaura Groupin hallitus ehdolliseen päätökseen Meriauran vähemmistöomistuksen myymisestä Meriaura Investille konsernin rahoituksen järjestelemiseksi Meriaura Group Oyj Yhtiötiedote, sisäpiiritieto                                                         25.4.2024 klo 14.00 (CEST) TÄYDENNYS – Sisäpiiritieto: Meriaura Groupin hallitus ehdolliseen päätökseen Meriauran vähemmistöomistuksen myymisestä Meriaura Investille konsernin rahoituksen järjestelemiseksi Tällä tiedotteella Meriaura Group Oyj täydentää aiemmin tänään 25.4.2024 klo 8.30 (CEST) antamaansa yhti...

 PRESS RELEASE

Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team...

Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement MUNICH, Germany, April 25, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”), a solar technology company, is pleased to announce a significant milestone in its corporate recovery. Following the successful conclusion of insolvency proceedings involving its subsidiary, Sono Motors GmbH, and the withdrawal of its own application for preliminary self-administration proceedings (reported in the Company’s Form 6-Ks filed on January 31, 2024 and February 29, 2024, respectively), th...

 PRESS RELEASE

Installed Building Products to Report First Quarter 2024 Financial Res...

COLUMBUS, Ohio--(BUSINESS WIRE)-- Installed Building Products, Inc. (the “Company”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today that the Company will release its first quarter 2024 financial results on May 9, 2024. A webcast and conference call will be held that same day at 10:00 a.m. (Eastern Time) to review the Company’s results. Webcast: The conference call will be available on the investor relations section of the Company’s website at . To listen to a live webcast, go to the site at least 15 minutes prior to the schedule...

 PRESS RELEASE

Compass Therapeutics Receives FDA Fast Track Designation for the Inves...

Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract cancer (BTC) in its Phase 2 study Top-line data readout for COMPANION-002, the Company’s randomized Phase 2/3 BTC U.S. study, is expected by the end of 2024 BOSTON, April 25, 2024 (GLO...

 PRESS RELEASE

Enviri Corporation to Participate in Upcoming Investor Conferences

Enviri Corporation to Participate in Upcoming Investor Conferences PHILADELPHIA, April 25, 2024 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the following upcoming investor conferences: Stifel – Waste 360 Investor Summit (Las Vegas)Monday, May 6, 2024Oppenheimer – 19th Annual Industrial Growth Conference (Virtual)Wednesday, May 8, 2024Stifel – 2024 Cross Sector Insight Conference (Boston – Webcast)Tuesday, June...

 PRESS RELEASE

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Redu...

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints “Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation CARSON CITY, Nev., April 25, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilita...

 PRESS RELEASE

Vegard Søraunet avböjer omval till SkiStars styrelse vid årsstämman i ...

Vegard Søraunet avböjer omval till SkiStars styrelse vid årsstämman i december Valberedningen inför årsstämman i december 2024 tillsatt Styrelseledamoten i SkiStar AB (publ) Vegard Søraunet har meddelat SkiStars valberedning att han avböjer omval vid SkiStars årsstämma, som avses hållas i december 2024. Detta till följd av ägarförändring i Nordic Ski & Mountains AB, som är större aktieägare i SkiStar. Søraunet, som representerar Aeternum Capital som fortsättningsvis är minoritetsägare i Nordic Ski & Mountains AB, har varit ledamot i SkiStars styrelse sedan årsstämman 2021. SkiStars ...

 PRESS RELEASE

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 ...

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held on May 5-9, 2024 in Seattle, Washington. ARVO 2024 Presentation Details: Title: Effect of Patient Baseline Characteristics on Respo...

 PRESS RELEASE

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financia...

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024 BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024. In addition, management will provid...

 PRESS RELEASE

Aquestive Therapeutics to Report First Quarter 2024 Financial Results ...

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET WARREN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the first quarter ended March 31, 2024 and provide an update on recent developments in its business after market...

 PRESS RELEASE

Banle Group Highlights Strategies for Sustainable Growth During Invest...

Banle Group Highlights Strategies for Sustainable Growth During Investor Webinar HONG KONG, April 25, 2024 (GLOBE NEWSWIRE) -- On April 23, 2024, Banle Group (the “Group”) (NASDAQ: BANL), a reputable marine fuel logistic company in the Asia Pacific region, hosted an Investor Webinar. During the webinar, Mr. Teck Lim Chia, Chairman and Chief Executive Officer, and Mr. Raymond Chiu, Chief Financial Officer, discussed the Group’s business strategies to sustain its leading position in the Asia Pacific market and further expand into the European market, the healthy and highly liquid nature of ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch